Administration of in vitro expanded bone marrow-derived endothelial progenitor cells (EPCs) contribute to the development of neointimal thickenings in mouse aortic allografts

YANG Zhao-hua,Tao Hong,ZHU Shi-jie,XIA Li-min,WANG Chun-sheng

DOI: https://doi.org/10.3969/j.issn.1672-8467.2012.04.006

2012-01-01

Abstract:Objective: To investigate the effect of bone narrow-derived endothelial progenitor cells (EPCs) on the intimal proliferation in a mouse model of transplant arteriosclerosis. Methods: EPCs were isolated from bone marrow-derived mouse mononuclear cells (MNCs) by using a Ficoll density gradient centrifugation, and then were cultured in endothelial basal medium. To establish a model of transplant arteriosclerosis, a segment of abdominal aorta was transplanted orthotopically from C57BL/6 to BALB/c mice. Then, 1×10 7/500 μL EPCs (n=18) or 500 μL vehicle (0.9% normal saline) was transplanted into the recipients byintravenous transfusion. The grafts were harvested at various time points after the operation, then endothelial regeneration rate and regional changes in the lumen and intimal were detected. Results: The adherent cells were considered EPCs which both showed spindle shape and had many endothelial characteristics. Two weeks after transplantation, compared with control group, transplantation of EPCs markedly accelerated endothelium injury of allografts. Four weeks later, the neointimal thickness in transplantation group was significantly higher than that of control group. Conclusions: EPCs may participate in the formation of the vascular lesion in aortic allografts. Bone marrow-derived EPCs promote endothelial damage and contribute to the neointima formation in a murine model of transplant arteriosclerosis.